260 related articles for article (PubMed ID: 26618253)
1. The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
Mayer O; Seidlerová J; Vaněk J; Karnosová P; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Windrichová J; Knapen MH; Drummen NE; Vermeer C
Int J Cardiol; 2016 Jan; 203():916-22. PubMed ID: 26618253
[TBL] [Abstract][Full Text] [Related]
2. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease.
Mayer O; Seidlerová J; Bruthans J; Filipovský J; Timoracká K; Vaněk J; Cerná L; Wohlfahrt P; Cífková R; Theuwissen E; Vermeer C
Atherosclerosis; 2014 Jul; 235(1):162-8. PubMed ID: 24835435
[TBL] [Abstract][Full Text] [Related]
3. The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A2.
Mayer O; Seidlerová J; Vaněk J; Kielbergerová L; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Trefil L; Knapen MH; Drummen NE; Vermeer C
Maturitas; 2015 Jan; 80(1):82-8. PubMed ID: 25458708
[TBL] [Abstract][Full Text] [Related]
4. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
[TBL] [Abstract][Full Text] [Related]
5. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
[TBL] [Abstract][Full Text] [Related]
6. The coincidence of low vitamin K status and high expression of growth differentiation factor 15 may indicate increased mortality risk in stable coronary heart disease patients.
Mayer O; Bruthans J; Seidlerová J; Karnosová P; Mateřánková M; Gelžinský J; Rychecká M; Opatrný J; Wohlfahrt P; Kučera R; Trefil L; Cífková R; Filipovský J; Vermeer C
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):540-551. PubMed ID: 33257192
[TBL] [Abstract][Full Text] [Related]
7. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population.
Mayer O; Seidlerová J; Wohlfahrt P; Filipovský J; Vaněk J; Cífková R; Windrichová J; Topolčan O; Knapen MH; Drummen NE; Vermeer C
J Hum Hypertens; 2016 Jul; 30(7):418-23. PubMed ID: 26016598
[TBL] [Abstract][Full Text] [Related]
8. Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.
Dahlberg S; Ede J; Schurgers L; Vermeer C; Kander T; Klarin B; Schött U
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303985
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K status and mortality after kidney transplantation: a cohort study.
Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH
Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995
[TBL] [Abstract][Full Text] [Related]
10. Circulating desphospho-uncarboxylated matrix γ-carboxyglutamate protein and the risk of coronary heart disease and stroke.
Dalmeijer GW; van der Schouw YT; Magdeleyns EJ; Vermeer C; Verschuren WM; Boer JM; Beulens JW
J Thromb Haemost; 2014 Jul; 12(7):1028-34. PubMed ID: 24826813
[TBL] [Abstract][Full Text] [Related]
11. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
[TBL] [Abstract][Full Text] [Related]
12. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
Aoun M; Makki M; Azar H; Matta H; Chelala DN
BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
[TBL] [Abstract][Full Text] [Related]
13. The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population.
Wei FF; Thijs L; Zhang ZY; Jacobs L; Yang WY; Salvi E; Citterio L; Cauwenberghs N; Kuznetsova T; E A Drummen N; Hara A; Manunta P; Li Y; Verhamme P; Allegaert K; Cusi D; Vermeer C; Staessen JA
Nephrol Dial Transplant; 2018 Mar; 33(3):514-522. PubMed ID: 28340119
[TBL] [Abstract][Full Text] [Related]
14. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.
Pivin E; Ponte B; Pruijm M; Ackermann D; Guessous I; Ehret G; Liu YP; Drummen NE; Knapen MH; Pechere-Bertschi A; Paccaud F; Mohaupt M; Vermeer C; Staessen JA; Vogt B; Martin PY; Burnier M; Bochud M
Hypertension; 2015 Jul; 66(1):85-92. PubMed ID: 25987667
[TBL] [Abstract][Full Text] [Related]
15. Matrix Gla Protein, Plaque Stability, and Cardiovascular Events in Patients with Severe Atherosclerotic Disease.
Zwakenberg SR; van der Schouw YT; Vermeer C; Pasterkamp G; den Ruijter HM; Beulens JWJ
Cardiology; 2018; 141(1):32-36. PubMed ID: 30304721
[TBL] [Abstract][Full Text] [Related]
16. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients.
Delanaye P; Krzesinski JM; Warling X; Moonen M; Smelten N; Médart L; Pottel H; Cavalier E
BMC Nephrol; 2014 Sep; 15():145. PubMed ID: 25190488
[TBL] [Abstract][Full Text] [Related]
17. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
[TBL] [Abstract][Full Text] [Related]
18. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
[TBL] [Abstract][Full Text] [Related]
19. Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population.
Liu YP; Gu YM; Thijs L; Knapen MH; Salvi E; Citterio L; Petit T; Carpini SD; Zhang Z; Jacobs L; Jin Y; Barlassina C; Manunta P; Kuznetsova T; Verhamme P; Struijker-Boudier HA; Cusi D; Vermeer C; Staessen JA
Hypertension; 2015 Feb; 65(2):463-70. PubMed ID: 25421980
[TBL] [Abstract][Full Text] [Related]
20. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH
PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
